1. Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin. (6th February 2017) Authors: Gouin‐Thibault, I.; Delavenne, X.; Blanchard, A.; Siguret, V.; Salem, J. E.; Narjoz, C.; Gaussem, P.; Beaune, P.; Funck‐Brentano, C.; Azizi, M.; Mismetti, P.; Loriot, M. A. Journal: Journal of thrombosis and haemostasis Issue: Volume 15:Number 2(2017) Page Start: 273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Multimodal assessment of non‐specific hemostatic agents for apixaban reversal. (5th February 2015) Authors: Martin, A.‐C.; Gouin‐Thibault, I.; Siguret, V.; Mordohay, A.; Samama, C.‐M.; Gaussem, P.; Le Bonniec, B.; Godier, A. Journal: Journal of thrombosis and haemostasis Issue: Volume 13:Number 3(2015:Mar.) Page Start: 426 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Multimodal assessment of non‐specific hemostatic agents for apixaban reversal. (5th February 2015) Authors: Martin, A.‐C.; Gouin‐Thibault, I.; Siguret, V.; Mordohay, A.; Samama, C.‐M.; Gaussem, P.; Le Bonniec, B.; Godier, A. Journal: Journal of thrombosis and haemostasis Issue: Volume 13:Number 3(2015:Mar.) Page Start: 426 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Platelet dysfunction associated with the novel Trp29Cys thromboxane A2 receptor variant. Issue 3 (13th March 2013) Authors: Mumford, A. D.; Nisar, S.; Darnige, L.; Jones, M. L.; Bachelot‐Loza, C.; Gandrille, S.; Zinzindohoue, F.; Fischer, A.‐M.; Mundell, S. J.; Gaussem, P. Journal: Journal of thrombosis and haemostasis Issue: Volume 11:Issue 3(2013) Page Start: 547 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗